Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cryo-Cell International, Inc. - Common Stock (NY:CCEL)

4.399 +0.079 (+1.83%)
Streaming Delayed Price Updated: 12:44 PM EDT, Sep 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cryo-Cell International, Inc. - Common Stock

Cryo-Cell International, Inc. Provides Dividend Update
From Cryo-Cell International, Inc.
Via Business Wire
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2025 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
Cord Blood Banking Leader Cryo-Cell Announces Cash Dividend
From Cryo-Cell International, Inc.
Via Business Wire
Looking Into Cryo-Cell International's Return On Capital Employed
 
Via Benzinga
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2025 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2024
From Cryo-Cell International, Inc.
Via Business Wire
Cord Blood Banking Leader Cryo-Cell Announces Regular Quarterly Cash Dividend and Pause of Strategic Initiatives
From Cryo-Cell International, Inc.
Via Business Wire
Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend
From Cryo-Cell International, Inc.
Via Business Wire
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
CCEL Stock Earnings: Cryo-Cell International Beats EPS, Beats Revenue for Q2 2024
CCEL stock results show that Cryo-Cell International beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
CCEL Stock Earnings: Cryo-Cell International Beats EPS, Misses Revenue for Q1 2024
CCEL stock results show that Cryo-Cell International beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value
From Cryo-Cell International, Inc.
Via Business Wire
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023
From Cryo-Cell International, Inc.
Via Business Wire
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2023 Financial Results
From Cryo-Cell International, Inc.
Via Business Wire
Why KalVista Pharmaceuticals Shares Are Trading Lower By 59%; Here Are 89 Biggest Movers From Yesterday
   Losers 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers 
Via Benzinga
Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day Session
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy. 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.